Biolumen

Biolumen Tech

San Francisco, United States · Founded 2018 · $20K raised

Employees
1–10
Founded
2018
Business Model
B2C
Total Funding
$20K
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 4 investors for this company. The full record is or through the API.

About

BioLumen is a San Francisco food-tech and biotech startup developing a natural, 3D-structured cellulose-based fiber that expands in the stomach to absorb sugar and fat, reducing the caloric and glycemic impact of food. Co-founded by Paolo Costa and endocrinologist Dr. Robert Lustig, its flagship product Monch Monch can absorb several times its weight in sugar and launched in the U.S. as a GRAS-designated probiotic beverage supplement. BioLumen is an alum of the IndieBio accelerator and the PepsiCo Greenhouse program.

Summary

Biolumen is a Biotech company based in San Francisco, United States, founded in 2018. It has raised $20K in total across 1 round. Investors include SOSV, IndieBio and Plug and Play Japan.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed Round
$20K

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Biolumen on Indexed.vc
<a href="https://indexed.vc/companies/biolumen"><img src="https://indexed.vc/api/badge/company/biolumen" alt="Biolumen on Indexed.vc" width="260" height="76" /></a>